While colorectal cancer polyps often have no symptoms—especially in the early stages—there are some warning signs to be on ...

The FDA broadened dupilumab's (Dupixent) approval as an add-on maintenance treatment for chronic rhinosinusitis with nasal ...

As we grapple with AI’s place on our roads, in our classrooms and alongside us in the workplace, there’s one realm in which ...

Following Priority Review, Dupixent is now available to patients as young as 12 years with inadequately controlled CRSwNPCurrent treatment ...

Many people are simply unaware of the existence of the FIT test or underestimate its importance in colorectal cancer ...

While the new Shield blood test may motivate more people to get screened for colorectal cancer, it also comes with downsides, ...

Colon capsule endoscopy offers a non-invasive alternative to traditional colonoscopy, improving early cancer detection and ...

Recommendation based on a Phase 3 trial showing a significantly greater proportion of children on Dupixent achieved histological remission ...

Developments in artificial intelligence (AI) are moving rapidly. Within gastroenterology, great interest and high expectations exist for computer-aided diagnosis (CADx) systems. These CADx systems ...

GSK receives Japanese MHLW approval for Nucala to treat adults with chronic rhinosinusitis with nasal polyps: London, UK Thursday, August 29, 2024, 09:00 Hrs [IST] GSK plc announc ...

AstraZeneca has announced that FluMist has been approved in the US as the self-administered influenza vaccine. FluMist, a ...